Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects

Clinical trial NCT02189772 · COMPLETED

Trial details

NCT number: NCT02189772
Sponsor: Alcobra Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ADHD, Predominantly Inattentive Type

Start date: 2014-08-01
Primary completion: 2015-01-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.